Vaccitech, Cancer Research UK, Ludwig begins dosing in phase 1/2a lung cancer trial

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Vaccitech, Cancer Research UK, Ludwig begins dosing in phase 1/2a lung cancer trial

To read the full story on Seeking Alpha, click here.

Vaccitech (NASDAQ:VACC)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Vaccitech Charts.

Vaccitech (NASDAQ:VACC)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Vaccitech Charts.

Vaccitech PLC News

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 7 November 2023 (6 months ago) • Edgar (US Regulatory)

Arbutus Doses First Patient in Additional Treatment Arm of Phase 2a Triple Combination Clinical Trial that Includes a PD-1 Monoclonal Antibody
Wednesday 21 June 2023 (10 months ago) • GlobeNewswire Inc.

More Vaccitech PLC News Articles

Alternet Systems (PK)

Marketing Worldwide (PK)

Bell Buckle (PK)

Umbra Applied Technologies (PK)

Yuenglings Ice Cream (PK)

Moon Equity (PK)

Auto Parts 4Less (PK)

Ubiquitech Software (PK)

AMC Entertainment

Astra Energy (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions